These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2894222)

  • 1. Is the ISA of pindolol beta 2-adrenoceptor selective?
    Aellig WH; Clark BJ
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):21S-28S. PubMed ID: 2894222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.
    Aellig WH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):187S-192S. PubMed ID: 6125169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
    Ades PA
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pindolol--the pharmacology of a partial agonist.
    Clark BJ; Menninger K; Bertholet A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):149S-158S. PubMed ID: 7049208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
    Williamson KL; Broadley KJ
    Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pindolol on vascular smooth muscle.
    Clark BJ; Bertholet A
    Gen Pharmacol; 1983; 14(1):117-9. PubMed ID: 6826021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additional properties of beta adrenoceptor blocking drugs.
    Prichard BN; Tomlinson B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
    Willette RN; Mitchell MP; Ohlstein EH; Lukas MA; Ruffolo RR
    Pharmacology; 1998 Jan; 56(1):30-6. PubMed ID: 9467185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
    Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
    Abrahamsson T
    Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor-blocking agents: are pharmacologic differences relevant?
    Clark BJ
    Am Heart J; 1982 Aug; 104(2 Pt 2):334-46. PubMed ID: 6125093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.